Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in

Rolando Pajon1, Peter T Beernink, Lee H Harrison

  • 1Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA.

Vaccine
|January 2, 2010
PubMed

Insights

Meningococcal factor H-binding protein (fHbp) has a modular structure, crucial for designing effective group B vaccines. Understanding fHbp variants and their expression is key to developing broad protection against meningococcal disease.

Area of Science:

  • Microbiology
  • Vaccinology
  • Immunology

Background:

  • Meningococcal factor H-binding protein (fHbp) is a key vaccine target.
  • fHbp exhibits sequence variability, classified into groups and sub-families.
  • Previous work established a modular architecture for fHbp.

Purpose of the Study:

  • To analyze new fHbp variants and classify them based on modular architecture.
  • To investigate the prevalence of different fHbp modular groups in invasive meningococcal disease isolates.
  • To assess the impact of fHbp modular groups and expression levels on vaccine-induced bactericidal activity.

Main Methods:

  • Sequence analysis of 172 new fHbp variants from public databases.
  • Classification of variants into previously defined modular groups.
  • Analysis of invasive group B isolates from the U.S. and Europe.
  • Testing mouse antisera against recombinant fHbp from different modular groups.

Main Results:

  • 172 new fHbp variants were classified into six previously defined modular groups.
  • Modular group I was most common overall, while group IV was prevalent in UK isolates but rare in U.S. isolates.
  • Antisera showed modular group-specific activity against low-expressing strains and broader activity against high-expressing strains.

Conclusions:

  • The modular architecture of fHbp is confirmed.
  • Both modular group and fHbp expression influence susceptibility to bactericidal antibodies.
  • Understanding fHbp modularity is vital for designing broadly protective group B vaccines regionally.

Related Concept Videos

Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...